IN2012DN05097A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN05097A IN2012DN05097A IN5097DEN2012A IN2012DN05097A IN 2012DN05097 A IN2012DN05097 A IN 2012DN05097A IN 5097DEN2012 A IN5097DEN2012 A IN 5097DEN2012A IN 2012DN05097 A IN2012DN05097 A IN 2012DN05097A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/17—Immunomodulatory nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Otolaryngology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28777709P | 2009-12-18 | 2009-12-18 | |
| EP10005348 | 2010-05-21 | ||
| PCT/EP2010/007751 WO2011072871A1 (en) | 2009-12-18 | 2010-12-17 | Production of ifn-lambda by conventional dendritic cells and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN05097A true IN2012DN05097A (en) | 2015-10-09 |
Family
ID=42321045
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN5097DEN2012 IN2012DN05097A (en) | 2009-12-18 | 2012-06-08 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9090897B2 (en) |
| EP (1) | EP2513311B9 (en) |
| JP (2) | JP2013514062A (en) |
| AU (1) | AU2010333322B2 (en) |
| CA (1) | CA2783510C (en) |
| DK (1) | DK2513311T4 (en) |
| ES (1) | ES2626595T5 (en) |
| IN (1) | IN2012DN05097A (en) |
| NZ (1) | NZ599677A (en) |
| WO (1) | WO2011072871A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013047869A1 (en) * | 2011-09-29 | 2013-04-04 | 興和株式会社 | Pharmaceutical composition containing loxoprofen or salt thereof |
| US9556439B2 (en) * | 2012-02-09 | 2017-01-31 | Bavarian Nordic A/S | Agonists and antagonists of toll-like receptor (TLR) 13 |
| WO2017175774A1 (en) * | 2016-04-04 | 2017-10-12 | キッコーマン株式会社 | COMPOSITION FOR PROMOTING INTERFERON λ PRODUCTION AND METHOD FOR PRODUCING SAME |
| CN107306939B (en) * | 2017-07-31 | 2020-09-15 | 山东水发生命科学研究有限公司 | Cell cryopreservation liquid for dendritic cells |
| EP3892739A1 (en) * | 2020-04-09 | 2021-10-13 | Centre Léon Bérard | Type iii interferon for use as a biomarker to predict response to a cancer treatment |
| CN114917242A (en) * | 2022-05-31 | 2022-08-19 | 复旦大学附属中山医院 | Application of synthetic double-stranded RNA analogue in preventing respiratory tract transmitted virus through nose dropping and application thereof |
| WO2024017998A1 (en) * | 2022-07-21 | 2024-01-25 | Technische Universität Dresden | M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression |
| EP4309666A1 (en) * | 2022-07-21 | 2024-01-24 | Technische Universität Dresden | M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3974167B2 (en) * | 1992-03-31 | 2007-09-12 | アーチ デベロプメント コーポレイション | Methods and compositions for treating genes, tumors and viral infections, and preventing programmed cell death (apoptosis) |
| US5554512A (en) | 1993-05-24 | 1996-09-10 | Immunex Corporation | Ligands for flt3 receptors |
| WO2002004002A2 (en) * | 2000-07-11 | 2002-01-17 | Bayer Aktiengesellschaft | Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| EP2572714A1 (en) | 2002-12-30 | 2013-03-27 | 3M Innovative Properties Company | Immunostimulatory Combinations |
| CN101018567B (en) * | 2004-07-20 | 2011-07-27 | 先灵公司 | Induction of apoptosis in Toll-like receptor expressing tumor cells |
| CA2587676A1 (en) * | 2004-11-19 | 2006-05-26 | Institut Gustave Roussy | Improved treatment of cancer by double-stranded rna |
| CN101652062A (en) * | 2007-03-05 | 2010-02-17 | 犹他州立大学 | Restrictive agonist of toll-like receptor 3 (tlr3) |
| JP5721428B2 (en) | 2007-04-27 | 2015-05-20 | バヴァリアン・ノルディック・アクティーゼルスカブ | Induction of dendritic cell development by macrophage-colony stimulating factor (M-CSF) |
| US8053234B2 (en) * | 2007-04-27 | 2011-11-08 | Bavarian Nordic A/S | Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF) |
| WO2009088401A2 (en) | 2007-09-24 | 2009-07-16 | Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Immunostimulatory combinations of tlr ligands and methods of use |
| US20100310600A1 (en) * | 2008-02-15 | 2010-12-09 | Carter William A | Selective agonist of toll-like receptor 3 |
-
2010
- 2010-12-17 JP JP2012543533A patent/JP2013514062A/en active Pending
- 2010-12-17 DK DK10795952.0T patent/DK2513311T4/en active
- 2010-12-17 CA CA2783510A patent/CA2783510C/en active Active
- 2010-12-17 NZ NZ599677A patent/NZ599677A/en not_active IP Right Cessation
- 2010-12-17 WO PCT/EP2010/007751 patent/WO2011072871A1/en not_active Ceased
- 2010-12-17 US US13/516,670 patent/US9090897B2/en active Active
- 2010-12-17 AU AU2010333322A patent/AU2010333322B2/en not_active Ceased
- 2010-12-17 ES ES10795952T patent/ES2626595T5/en active Active
- 2010-12-17 EP EP10795952.0A patent/EP2513311B9/en active Active
-
2012
- 2012-06-08 IN IN5097DEN2012 patent/IN2012DN05097A/en unknown
-
2016
- 2016-01-07 JP JP2016001627A patent/JP6263559B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DK2513311T3 (en) | 2017-07-24 |
| NZ599677A (en) | 2014-10-31 |
| DK2513311T4 (en) | 2021-06-14 |
| WO2011072871A1 (en) | 2011-06-23 |
| JP2016121157A (en) | 2016-07-07 |
| AU2010333322A1 (en) | 2012-05-24 |
| EP2513311B9 (en) | 2021-08-18 |
| JP2013514062A (en) | 2013-04-25 |
| ES2626595T3 (en) | 2017-07-25 |
| US9090897B2 (en) | 2015-07-28 |
| JP6263559B2 (en) | 2018-01-17 |
| EP2513311B1 (en) | 2017-04-12 |
| EP2513311A1 (en) | 2012-10-24 |
| ES2626595T5 (en) | 2021-11-24 |
| CA2783510C (en) | 2019-01-08 |
| CA2783510A1 (en) | 2011-06-23 |
| AU2010333322B2 (en) | 2016-02-04 |
| EP2513311B2 (en) | 2021-03-24 |
| US20120258082A1 (en) | 2012-10-11 |